← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Spectragenetics
Pittsburgh, PA
$6,472,895
Total funding
7
Grants
Funding over time
peak $968.8K · FY2006–24$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,472,895 · 7
By mechanism
R44$5,606,257 · 3
R43$643,921 · 3
R41$222,717 · 1
Investigators at Spectragenetics
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Highly Multiplexed Cell-Based GPCR Assay.$893,166
R44 · FY2024 · MH
Highly Multiplexed Cell-Based GPCR Assay.$711,325
R44 · FY2022 · MH
Highly Multiplexed Cell-Based GPCR Assay.$661,142
R44 · FY2023 · MH
Analysis of Tumor RNA Variants using PMSG$646,382
R44 · FY2006 · CA
Analysis of Tumor RNA Variants using PMSG$581,738
R44 · FY2007 · CA
Cancer Genotyping by Peptide Mass Spectrometry$474,813
R44 · FY2003 · GM
Cancer Genotyping by Peptide Mass Spectrometry$472,940
R44 · FY2004 · GM
Highly Multiplexed Cell-Based GPCR Assay.$431,799
R44 · FY2020 · MH
Highly Multiplexed Cell-Based GPCR Assay.$425,279
R44 · FY2021 · MH
Highly Multiplexed Cell-Based GPCR Assay.$307,673
R44 · FY2023 · MH
SCALABLE MULTIPLEXED MICROARRAY ASSAY FOR RECEPTOR DOWNREGULATION$230,519
R43 · FY2017 · MH
Highly multiplexed live-cell GPCR arrays for drug discovery in glioma.$222,717
R41 · FY2021 · CA
SCALABLE MULTIPLEXED MICROARRAY ASSAY FOR RECEPTOR DOWNREGULATION$213,765
R43 · FY2016 · MH
In Vitro Peptide Mass-Signature Genotyping of Tumor DNA$99,966
R43 · FY2004 · CA
Detection of Tumor RNA Variants using PMSG$99,671
R43 · FY2004 · CA